265 related articles for article (PubMed ID: 36221140)
1. Impact of the national hepatitis B immunization program in China: a modeling study.
Liu Z; Li M; Hutton DW; Wagner AL; Yao Y; Zhu W; Cao L; Tang S; Pan J; Wang Y; Zhao Q; Ren H; Wang Y; Wang W
Infect Dis Poverty; 2022 Oct; 11(1):106. PubMed ID: 36221140
[TBL] [Abstract][Full Text] [Related]
2. [Economic evaluation and prediction of hepatitis B immunization strategy in Shenzhen, China].
Sun PP; Zhang SX; Xia Y
Zhonghua Yu Fang Yi Xue Za Zhi; 2018 Jul; 52(7):743-747. PubMed ID: 29996303
[No Abstract] [Full Text] [Related]
3. Cost-effectiveness analysis of a hepatitis B vaccination catch-up program among children in Shandong Province, China.
Jia Y; Li L; Cui F; Zhang D; Zhang G; Wang F; Gong X; Zheng H; Wu Z; Miao N; Sun X; Zhang L; Lv J; Yang F
Hum Vaccin Immunother; 2014; 10(10):2983-91. PubMed ID: 25483678
[TBL] [Abstract][Full Text] [Related]
4. [Economic evaluation on strategy for preventing mother-to-child transmission of hepatitis B in Zhejiang Province].
Zeng YB; Luo ML; He HQ; Deng X; Xie SY; Fang Y
Zhonghua Yu Fang Yi Xue Za Zhi; 2019 Jul; 53(7):706-712. PubMed ID: 31288342
[No Abstract] [Full Text] [Related]
5. Selective Hepatitis B Birth-Dose Vaccination in São Tomé and Príncipe: A Program Assessment and Cost-Effectiveness Study.
Hagan JE; Carvalho E; Souza V; Queresma Dos Anjos M; Abimbola TO; Pallas SW; Tevi Benissan MC; Shendale S; Hennessey K; Patel MK
Am J Trop Med Hyg; 2019 Oct; 101(4):891-898. PubMed ID: 31392947
[TBL] [Abstract][Full Text] [Related]
6. [Cost-effectiveness and cost-benefit analysis on strategy for preventing mother-to-child transmission of hepatitis B virus].
Cai YL; Zhang SX; Yang PC; Lin Y
Zhonghua Liu Xing Bing Xue Za Zhi; 2016 Jun; 37(6):846-51. PubMed ID: 27346114
[TBL] [Abstract][Full Text] [Related]
7. Cost-Benefit Analysis of Vaccination Strategies to Prevent Mother-to-Child Transmission of the Hepatitis B Virus Using a Markov Model Decision Tree.
Yang N; Lei L; Meng Y; Zhou N; Shi L; Hu M
Front Public Health; 2022; 10():662442. PubMed ID: 35801242
[TBL] [Abstract][Full Text] [Related]
8. Requirements for global elimination of hepatitis B: a modelling study.
Nayagam S; Thursz M; Sicuri E; Conteh L; Wiktor S; Low-Beer D; Hallett TB
Lancet Infect Dis; 2016 Dec; 16(12):1399-1408. PubMed ID: 27638356
[TBL] [Abstract][Full Text] [Related]
9. A mathematical model of hepatitis B virus transmission and its application for vaccination strategy in china.
Zhao S; Xu Z; Lu Y
Int J Epidemiol; 2000 Aug; 29(4):744-52. PubMed ID: 10922354
[TBL] [Abstract][Full Text] [Related]
10. Benefits of early hepatitis B immunization programs for newborns and infants.
Van Herck K; Van Damme P
Pediatr Infect Dis J; 2008 Oct; 27(10):861-9. PubMed ID: 18776823
[TBL] [Abstract][Full Text] [Related]
11. Status and progress of hepatitis B control through vaccination in the South-East Asia Region, 1992-2015.
Childs L; Roesel S; Tohme RA
Vaccine; 2018 Jan; 36(1):6-14. PubMed ID: 29174317
[TBL] [Abstract][Full Text] [Related]
12. Progress towards elimination of mother-to-child transmission of hepatitis B virus infection in China: a modelling analysis.
Hui Z; Nayagam S; Chan P; Fuzhen W; Thursz M; Zundong Y; Ning M; Xiaojin S; Cui F; Guomin Z; Hallett TB
Bull World Health Organ; 2021 Jan; 99(1):10-18. PubMed ID: 33658732
[TBL] [Abstract][Full Text] [Related]
13. Impact and Cost-Effectiveness of Biomedical Interventions on Adult Hepatitis B Elimination in China: A Mathematical Modelling Study.
Wang X; Du Z; Wang Y; Wang J; Huang S; Wang Y; Gu J; Deng W; Gilmour S; Li J; Hao Y
J Epidemiol Glob Health; 2023 Sep; 13(3):517-527. PubMed ID: 37349664
[TBL] [Abstract][Full Text] [Related]
14. Impact and cost-effectiveness of hepatitis B virus prophylaxis in pregnancy: a dynamic simulation modelling study.
Nayagam S; de Villiers MJ; Shimakawa Y; Lemoine M; Thursz MR; Walsh N; Hallett TB
Lancet Gastroenterol Hepatol; 2023 Jul; 8(7):635-645. PubMed ID: 37150181
[TBL] [Abstract][Full Text] [Related]
15. Integrated approach for triple elimination of mother-to-child transmission of HIV, hepatitis B and syphilis is highly effective and cost-effective: an economic evaluation.
Zhang L; Tao Y; Woodring J; Rattana K; Sovannarith S; Rathavy T; Cheang K; Hossain S; Ferradini L; Deng S; Sokun C; Samnang C; Nagai M; Lo YR; Ishikawa N
Int J Epidemiol; 2019 Aug; 48(4):1327-1339. PubMed ID: 30879066
[TBL] [Abstract][Full Text] [Related]
16. Prevention of hepatitis B virus transmission by immunization. An economic analysis of current recommendations.
Margolis HS; Coleman PJ; Brown RE; Mast EE; Sheingold SH; Arevalo JA
JAMA; 1995 Oct; 274(15):1201-8. PubMed ID: 7563509
[TBL] [Abstract][Full Text] [Related]
17. Cost-effectiveness of screening and vaccinating Asian and Pacific Islander adults for hepatitis B.
Hutton DW; Tan D; So SK; Brandeau ML
Ann Intern Med; 2007 Oct; 147(7):460-9. PubMed ID: 17909207
[TBL] [Abstract][Full Text] [Related]
18. Hepatitis B vaccination in children: the Taiwan experience.
Ni YH; Chen DS
Pathol Biol (Paris); 2010 Aug; 58(4):296-300. PubMed ID: 20116181
[TBL] [Abstract][Full Text] [Related]
19. Tenofovir prophylaxis for preventing mother-to-child hepatitis B virus transmission in China: A cost-effectiveness analysis.
Yin J; Liang P; Chen G; Wang F; Cui F; Liang X; Zhuang G
Int J Infect Dis; 2020 Jun; 95():118-124. PubMed ID: 32205288
[TBL] [Abstract][Full Text] [Related]
20. Progress Toward Hepatitis B Control and Elimination of Mother-to-Child Transmission of Hepatitis B Virus - Western Pacific Region, 2005-2017.
Woodring J; Pastore R; Brink A; Ishikawa N; Takashima Y; Tohme RA
MMWR Morb Mortal Wkly Rep; 2019 Mar; 68(8):195-200. PubMed ID: 30817746
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
